SC 13D

Company

China SXT Pharmaceuticals, Inc.

Filed

February 15, 2019

Accession Number

0001144204-19-008588

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →